美国性别肯定顶部手术的保险覆盖情况
该研究对美国57家保险公司的性别肯定顶部手术覆盖政策进行横断面分析,发现双侧乳房切除术(跨性别男性化)的覆盖显著高于乳房增大术(跨性别女性化)(96% vs 68%,p<0.0001),仅4%公司使用与WPATH推荐一致的 criteria,且各公司附加了WPATH指南之外的覆盖前提条件。
要点
- 跨性别男性化顶部手术保险覆盖显著高于女性化(96% vs 68%,p<0.0001)
- 仅4%保险公司使用与WPATH推荐一致的医疗必要性标准
- 跨性别女性化政策要求术前激素治疗的比例显著更高(90% vs 21%,p<0.0001)
核心结论
- 保险公司间覆盖标准差异显著且常偏离WPATH推荐,部分保险公司完全拒绝性别肯定顶部手术的覆盖。
- 需要更多证据基础以支持当前使用的医疗必要性标准。
研究设计与样本
- 横断面分析保险政策,基于州注册数据和市场份额选择57家保险公司。
- 通过网页搜索和个人电话访谈识别政策,从公开政策中提取医疗必要性标准。
主要发现
- 57家保险公司中,双侧乳房切除术(跨性别男性化)覆盖率为96%,乳房增大术(跨性别女性化)覆盖率为68%(p<0.0001)。
- 仅4%的公司使用与WPATH一致的 criteria。
- 没有任何一项标准被所有保险公司普遍要求。
- 超出WPATH指南的额外覆盖前提包括:持续以认同性别角色生活、两名转诊精神卫生专业人员、术前激素治疗。
- 跨性别女性化政策要求激素治疗的比例显著高于跨性别男性化政策(90% vs 21%,p<0.0001)。
关键数值与推荐
- 双侧乳房切除术覆盖率为96%,乳房增大术覆盖率为68%(p<0.0001)。
- 使用WPATH一致标准的公司占4%。
- 跨性别女性化政策要求激素治疗的比例为90%,跨性别男性化为21%(p<0.0001)。
临床怎么用
- 临床医生在申请性别肯定顶部手术保险覆盖时,需了解不同保险公司标准差异大且常偏离WPATH推荐。
- 应关注保险公司可能要求的额外前提条件(如持续认同性别角色生活、两名精神卫生专业人员转诊、术前激素治疗),并据此准备申请材料。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the medical necessity, legislative mandates, and economic benefits of gender-affirming surgery, access to treatment remains limited. The World Professional Association for Transgender Health (WPATH) has proposed guidelines for transition-related surgery in conjunction with criteria to delineate medical necessity. The authors assessed insurance coverage of "top" gender-affirming surgery and evaluated the differences between insurance policy criteria and WPATH recommendations. METHODS: The authors conducted a cross-sectional analysis of insurance policies for coverage of top gender-affirming surgery. Insurance companies were selected based on their state enrollment data and market share. A Web-based search and individual telephone interviews were conducted to identify the policy. Medical necessity criteria were abstracted from publicly available policies. RESULTS: Of the 57 insurers evaluated, bilateral mastectomy (transmasculine) was covered by significantly more insurers than breast augmentation (transfeminine) (96 percent versus 68 percent; p < 0.0001). Only 4 percent of companies used WPATH-consistent criteria. No criterion was universally required by insurers. Additional prerequisites for coverage that extended beyond WPATH guidelines for top surgery were continuous living in congruent gender role, two referring mental health professionals, and hormone therapy before surgery. Hormone therapy was required in a significantly higher proportion of transfeminine policies compared with transmasculine policies (90 percent versus 21 percent; p < 0.0001). CONCLUSIONS: In addition to the marked intercompany variation in criteria for insurance coverage that often deviated from WPATH recommendations, there are health care insurers who categorically deny access to top gender-affirming surgery. A greater evidence base is needed to provide further support for the medical necessity criteria in current use.
引用
- Ngaage LM, Knighton BJ, McGlone KL, et al. Health Insurance Coverage of Gender-Affirming Top Surgery in the United States. Plast Reconstr Surg. 2019. PMID: 31568285. doi:10.1097/PRS.0000000000006012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。